House Subcommittee Reaffirms Health-Care Fraud Focus
Executive Summary
Representatives from both parties questioned US federal officials and a contractor as to what could be done to more efficiently stop fraud.
You may also be interested in...
Olympus Pays Record Anti-Kickback Penalty For Device Case
The endoscope-maker resolved a federal investigation into kickbacks with a $600-million-plus payment, as well as a deferred prosecution agreement and a corporate integrity agreement that come with serious commitments to improving compliance.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.